SM Marken GMBH – Trademark Portfolio
Entity Type: 16
SM Marken GMBH holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include SHICK, BINNER, U.V.3., QUALITOR, and SANI CAR. The owner is based in Zug.
Intertrust Services (Schweiz) AG
Alpenstrasse 15 6304
Zug 00000 , CH
Showing of trademarks Trademarks
Trademark Classifications
SM Marken GMBH's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does SM Marken GMBH have?
SM Marken GMBH has 11 U.S. trademarks filed with the USPTO. Of these, 7 registered, 2 abandoned, 2 cancelled.
What trademark classes does SM Marken GMBH file in?
SM Marken GMBH files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 12 (Vehicles). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are SM Marken GMBH's most well-known trademarks?
SM Marken GMBH's registered trademark portfolio includes well-known marks such as SHICK, BINNER, U.V.3., QUALITOR, and SANI CAR. These are among 7 currently registered trademarks in the portfolio.
What is SM Marken GMBH's trademark registration success rate?
SM Marken GMBH has a 64% trademark registration rate, with 7 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.